Sexual DysfunctionNCT04662398
Using of Testes' Shocker in Improving Sexual Activity
A study testing JT Device in people with Sexual Dysfunction and Sexual Abstinence, run by University of Baghdad at 1 site in Iraq.
Trial summary
Using of testes' shocker in treating the sexual dysfunction. Read more about this study
- Who is it for?
- Ages 20 years and older, men only
- Conditions the study is for
- Sexual Dysfunction, Sexual Abstinence, Sexual Desire Disorder
- What is being tested?
- JT Device
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 77 participants
- Where
- 1 siteIraq
- Study dates
- 5 Dec 2020to 15 Jan 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All patients with sexual dysfunction or erectile dysfunction
Who cannot join
- Patients with trauma or other causes that make them inactive sexually
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Using of Testes' Shocker in Treating Sexual Disease and Dysfunction
Using of testes' shocker in treating the sexual dysfunction.
Read the detailed description
Using of electrical shocks in treating sexual dysfunction in males, rectile dysfunction and inability to perform sexually good.
- Conditions
- Sexual Dysfunction, Sexual Abstinence, Sexual Desire Disorder, Erectile Dysfunction, Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction Following Cryotherapy
- Being tested
- JT Device
- Medical subject headings
- Sexual Dysfunction, Physiological, Sexual Abstinence, Erectile Dysfunction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
JT DeviceDevice
Also called Testes shocker
Shocker giving electrical shocks on testes
| Study group | Role | What they receive |
|---|---|---|
| Case (Testes shocker device) | Active comparator | The shocker will be used in delivering the current gradually on the testes and penis to improve the blood flow and stimulates the sexual activity among males. Receives: Device: JT Device |
| Control (non testes shocker device) | Sham comparator | These groups will not given the shocks, shame device will be used instead and then compare the two results. Receives: Device: JT Device |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sexual desire
improving the desire of sex by using the electric shocks directly on the testes and penis. This will be assessed by a questionnaire (validated and reliable) to assess their ability to have sex more actively or not.
Measured: less than one month
Erectile dysfunction
solving the problem of erectile dysfunction and this will be assessed by examination and experience to see if there is an effect for the electric shocks on erectile improvement.
Measured: less than one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Dec 2020
- Study start5 Dec 2020
- Primary completion14 Jan 2021
- Study completion15 Jan 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sexual DysfunctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Case control
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 77 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Baghdad
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hashim Talib Hashim, University of Baghdad
- Investigators
- Ali Al Imam, MD, Principal investigator, University of Mosul
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04662398
- Sponsor's protocol ID
- HT98
- Status last verified
- Oct 2022
- First submitted
- 28 Nov 2020
- Last updated
- 1 Nov 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using of Testes' Shocker in Treating Sexual Disease and Dysfunction
- ClinicalTrials.gov ID
- NCT04662398
- Acronym / sponsor ID
- HT98
- Conditions
- Sexual Dysfunction, Sexual Abstinence, Sexual Desire Disorder, Erectile Dysfunction, Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction Following Cryotherapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 77 participants (actual)
- Lead sponsor
- University of BaghdadUniversity, hospital or other
- Study start
- 5 Dec 2020 (actual)
- Primary completion
- 14 Jan 2021 (actual)
- Study completion
- 15 Jan 2021 (actual)
- First posted
- 10 Dec 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Using of testes' shocker in treating the sexual dysfunction.
Detailed description
Using of electrical shocks in treating sexual dysfunction in males, rectile dysfunction and inability to perform sexually good.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 2
- Model description
- Case control
| Arm | Type | Receives |
|---|---|---|
| Case (Testes shocker device) | Active comparator | Device: JT DeviceThe shocker will be used in delivering the current gradually on the testes and penis to improve the blood flow and stimulates the sexual activity among males. |
| Control (non testes shocker device) | Sham comparator | Device: JT DeviceThese groups will not given the shocks, shame device will be used instead and then compare the two results. |
Who may qualify
- Ages
- 20 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All patients with sexual dysfunction or erectile dysfunction
Key exclusion criteria (1 listed)
- Patients with trauma or other causes that make them inactive sexually
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| JT DeviceAlso: Testes shockerShocker giving electrical shocks on testes | Device | Case (Testes shocker device), Control (non testes shocker device) |
Primary outcome
Sexual desire
Time frame: less than one month
improving the desire of sex by using the electric shocks directly on the testes and penis. This will be assessed by a questionnaire (validated and reliable) to assess their ability to have sex more actively or not.
Erectile dysfunction
Time frame: less than one month
solving the problem of erectile dysfunction and this will be assessed by examination and experience to see if there is an effect for the electric shocks on erectile improvement.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Nov 2022.
- Individual participant dataSharing planned: No
Related trials for Sexual Dysfunction
RecruitingObservational study
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
Turner Syndrome, Post-menarcheal Adolescents
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
RecruitingPhase 4
Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's Disease
Peyronie's Disease
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingPhase 3
A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients
Erectile Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ali Al Imam, MD principal investigator
University of Mosul
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing JT Device in people with Sexual Dysfunction and Sexual Abstinence, run by University of Baghdad at 1 site in Iraq.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sexual desire (time frame: less than one month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2022.